BA
SRGA

Boston Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Boston Advisors’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,357
Closed -$379K – 598
2013
Q2 		$379K Buy
+3,357
New +$411K 0.02% 350

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Boston Advisors's SRGA Position: Q3 2013 in Review

Boston Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2013, closing a stake of 3,357 shares — an estimated $379K sold.

Boston Advisors first reported a position in SRGA in Q2 2013 and held it in 1 quarter. The position peaked at $379K in Q2 2013. 106 funds tracked by Wall St. Rank hold SRGA as of Q3 2013.

  • Boston Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Boston Advisors sold 3,357 Surgalign Holdings, Inc. Common Stock shares in Q3 2013, an estimated $379K.
  • Boston Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Boston Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $379K in Q2 2013.
  • 106 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2013.

Based on Boston Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.